Terms: = Ovarian cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
32 results:
1. diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
[TBL] [Abstract] [Full Text] [Related]
2. ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
[TBL] [Abstract] [Full Text] [Related]
3. Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa.
Kokori E; Olatunji G; Ogieuhi IJ; Muogbo I; Isarinade D; Ukoaka B; Ajayi I; Ezenwoba C; Samuel O; Nurudeen-Busari H; Olawade DB; Aderinto N
Medicine (Baltimore); 2024 Feb; 103(5):e37154. PubMed ID: 38306573
[TBL] [Abstract] [Full Text] [Related]
4. Pregnancy After Breast cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
Lambertini M; Blondeaux E; Agostinetto E; Hamy AS; Kim HJ; Di Meglio A; Bernstein Molho R; Hilbers F; Pogoda K; Carrasco E; Punie K; Bajpai J; Ignatiadis M; Moore HCF; Phillips KA; Toss A; Rousset-Jablonski C; Peccatori FA; Renaud T; Ferrari A; Paluch-Shimon S; Fruscio R; Cui W; Wong SM; Vernieri C; Ruddy KJ; Dieci MV; Matikas A; Rozenblit M; Villarreal-Garza C; De Marchis L; Del Mastro L; Puglisi F; Del Pilar Estevez-Diz M; Rodriguez-Wallberg KA; Mrinakova B; Meister S; Livraghi L; Clatot F; Yerushalmi R; De Angelis C; Sánchez-Bayona R; Meattini I; Cichowska-Cwalinska N; Berlière M; Salama M; De Giorgi U; Sonnenblick A; Chiodi C; Lee YJ; Maria C; Azim HA; Boni L; Partridge AH;
JAMA; 2024 Jan; 331(1):49-59. PubMed ID: 38059899
[TBL] [Abstract] [Full Text] [Related]
5. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
6. Effect of differences in O-RADS lexicon interpretation between senior and junior sonologists on O-RADS classification and diagnostic performance.
Yang Y; Wang H; Liu Z; Su N; Gao L; Tao X; Zhang R; Gu Y; Ma L; Wang R; Xu W; Xie Y; Zhang W; Zhang H; Xue G; Ru T; Dai Q; Li J; Jiang Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12275-12283. PubMed ID: 37430161
[TBL] [Abstract] [Full Text] [Related]
7. Trends in the incidence of ovarian cancer in sub-Saharan Africa.
Gizaw M; Parkin DM; Stöter O; Korir A; Kamate B; Liu B; Bojang L; N'Da G; Manraj SS; Bukirwa P; Chokunonga E; Chingonzoh T; Peko JF; Finesse A; Somdyala N; Ladipo A; Kantelhardt EJ
Int J Cancer; 2023 Apr; 152(7):1328-1336. PubMed ID: 36274630
[TBL] [Abstract] [Full Text] [Related]
8. HER2 Expression in Endometrial cancers Diagnosed as Clear Cell Carcinoma.
Cagaanan A; Stelter B; Vu N; Rhode EN; Stewart T; Hui P; Buza N; Al-Niaimi A; Flynn C; Weisman PS; McGregor SM
Int J Gynecol Pathol; 2022 Mar; 41(2):132-141. PubMed ID: 33782344
[TBL] [Abstract] [Full Text] [Related]
9. [Digestive Surgery Intervention for Gynecological Malignant Tumor].
Kameyama H; Shimada Y; Abe K; Oyanagi H; Nakano M; Nakano M; Ichikawa H; Hanyu T; Takizawa K; Nagahashi M; Sakata J; Kobayashi T; Nishikawa N; Enomoto T; Wakai T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2176-2178. PubMed ID: 32156870
[TBL] [Abstract] [Full Text] [Related]
10. Proteomic analysis in endometrial cancer and endometrial hyperplasia tissues by 2D-DIGE technique.
Ceylan Y; Akpınar G; Doger E; Kasap M; Guzel N; Karaosmanoglu K; Kopuk SY; Yucesoy I
J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101652. PubMed ID: 31783195
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and ovarian cancer Screening Trial.
Pinsky PF; Black A; Daugherty SE; Hoover R; Parnes H; Smith ZL; Eggener S; Andriole GL; Berndt SI
Cancer; 2019 Sep; 125(17):2965-2974. PubMed ID: 31067347
[TBL] [Abstract] [Full Text] [Related]
12. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and ovarian randomized cancer screening trial.
Pinsky PF; Miller E; Prorok P; Grubb R; Crawford ED; Andriole G
BJU Int; 2019 May; 123(5):854-860. PubMed ID: 30288918
[TBL] [Abstract] [Full Text] [Related]
13. Proton pump inhibitor use and cancer mortality.
Tvingsholm SA; Dehlendorff C; Østerlind K; Friis S; Jäättelä M
Int J Cancer; 2018 Sep; 143(6):1315-1326. PubMed ID: 29658114
[TBL] [Abstract] [Full Text] [Related]
14. Pre-diagnosis diet and survival after a diagnosis of ovarian cancer.
Playdon MC; Nagle CM; Ibiebele TI; Ferrucci LM; Protani MM; Carter J; Hyde SE; Neesham D; Nicklin JL; Mayne ST; Webb PM
Br J Cancer; 2017 Jun; 116(12):1627-1637. PubMed ID: 28463959
[TBL] [Abstract] [Full Text] [Related]
15. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.
Köbel M; Atenafu EG; Rambau PF; Ferguson SE; Nelson GS; Ho TC; Panzarella T; McAlpine JN; Gilks CB; Clarke BA; Bernardini MQ
Gynecol Oncol; 2016 Jun; 141(3):559-563. PubMed ID: 27072807
[TBL] [Abstract] [Full Text] [Related]
16. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
[TBL] [Abstract] [Full Text] [Related]
17. An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
Li K; Hüsing A; Fortner RT; Tjønneland A; Hansen L; Dossus L; Chang-Claude J; Bergmann M; Steffen A; Bamia C; Trichopoulos D; Trichopoulou A; Palli D; Mattiello A; Agnoli C; Tumino R; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HB; Gram IT; Weiderpass E; Sánchez-Cantalejo E; Chirlaque MD; Duell EJ; Ardanaz E; Idahl A; Lundin E; Khaw KT; Travis RC; Merritt MA; Gunter MJ; Riboli E; Ferrari P; Terry K; Cramer D; Kaaks R
Br J Cancer; 2015 Mar; 112(7):1257-65. PubMed ID: 25742479
[TBL] [Abstract] [Full Text] [Related]
18. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.
Nagle CM; Ibiebele TI; DeFazio A; Protani MM; Webb PM;
Cancer Epidemiol; 2015 Apr; 39(2):196-9. PubMed ID: 25666512
[TBL] [Abstract] [Full Text] [Related]
19. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis.
Wu J; Xie X; Nie S; Buckanovich RJ; Lubman DM
J Proteome Res; 2013 Jul; 12(7):3342-52. PubMed ID: 23731285
[TBL] [Abstract] [Full Text] [Related]
20. [State of health of populations residing in geothermal areas of Tuscany].
Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
[TBL] [Abstract] [Full Text] [Related]
[Next]
